Cellular and Molecular Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran.
Department of Pathology, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
Front Immunol. 2022 Jun 2;13:842745. doi: 10.3389/fimmu.2022.842745. eCollection 2022.
Surfactant proteins (SPs) are important for normal lung function and innate immunity of the lungs and their genes have been identified with significant genetic variability. Changes in quantity or quality of SPs due to genetic mutations or natural genetic variability may alter their functions and contribute to the host susceptibility for particular diseases. Alternatively, SP single nucleotide polymorphisms (SNPs) can serve as markers to identify disease risk or response to therapies, as shown for other genes in a number of other studies. In the current study, we evaluated associations of SNPs with idiopathic pulmonary fibrosis (IPF) by studying novel computational models where the epistatic effects (dominant, additive, recessive) of SNP-SNP interactions could be evaluated, and then compared the results with a previously published hypersensitivity pneumonitis (HP) study where the same novel models were used. Mexican Hispanic patients (IPF=84 & HP=75) and 194 healthy control individuals were evaluated. The goal was to identify SP SNPs and SNP-SNP interactions that associate with IPF as well as SNPs and interactions that may be unique to each of these interstitial diseases or common between them. We observed: 1) in terms of IPF, i) three single SNPs to associate with decreased IPF risk, ii) three haplotypes to associate with increased IPF risk, and iii) a number of three-SNP interactions to associate with IPF susceptibility. 2) Comparison of IPF and HP, i) three and one SNP associated with decreased risk in IPF but increased risk in HP, and one SNP associated with decreased risk in both IPF and HP, ii) a number of three-SNP interactions with the same or different effect pattern associated with IPF and/or HP susceptibility, iii) one of the three-SNP interactions that involved SNPs of , , and , with the same effect pattern, was associated with a disease-specific outcome, a decreased and increased risk in HP and IPF, respectively. This is the first study that compares the SP gene variants in these two phenotypically similar diseases. Our findings indicate that SNPs of all may play an important role in the genetic susceptibility to IPF and HP. Importantly, IPF and HP share some SP genetic variants, suggesting common pathophysiological mechanisms and pathways regarding surfactant biogenesis, but also some differences, highlighting the diverse underlying pathogenic mechanisms between an inflammatory-driven fibrosis (HP) and an epithelial-driven fibrosis (IPF). Alternatively, the significant SNPs identified here, along with SNPs of other genes, could serve as markers to distinguish these two devastating diseases.
表面活性蛋白(SPs)对正常肺功能和肺部先天免疫至关重要,其基因已被确定具有显著的遗传变异性。由于基因突变或自然遗传变异导致 SPs 的数量或质量发生变化,可能会改变它们的功能,并导致宿主对特定疾病的易感性发生变化。或者,SP 单核苷酸多态性(SNP)可以作为标记来识别疾病风险或对治疗的反应,就像其他许多研究中的其他基因一样。在本研究中,我们通过研究新的计算模型来评估 SNP 与特发性肺纤维化(IPF)之间的关联,该模型可以评估 SNP-SNP 相互作用的上位效应(显性、相加、隐性),然后将结果与之前发表的过敏性肺炎(HP)研究进行比较,该研究中使用了相同的新模型。评估了墨西哥裔西班牙裔患者(IPF=84 例和 HP=75 例)和 194 名健康对照个体。目的是确定与 IPF 相关的 SP SNP 和 SNP-SNP 相互作用,以及可能与这些间质性疾病中的每一种相关或共同存在的 SNP 和相互作用。我们观察到:1)就 IPF 而言,i)三个单 SNP 与降低 IPF 风险相关,ii)三个单倍型与增加 IPF 风险相关,iii)许多三个 SNP 相互作用与 IPF 易感性相关。2)比较 IPF 和 HP,i)三个 SNP 和一个 SNP 与 IPF 风险降低但 HP 风险增加相关,一个 SNP 与 IPF 和 HP 风险降低相关,ii)许多具有相同或不同效应模式的三个 SNP 相互作用与 IPF 和/或 HP 易感性相关,iii)涉及 SNP 、 、和 的三个 SNP 相互作用之一,具有相同的效应模式,与特定疾病的结果相关,分别是 HP 和 IPF 中的风险降低和增加。这是首次比较这两种表型相似疾病中 SP 基因变异的研究。我们的研究结果表明,所有 基因的 SNP 都可能在 IPF 和 HP 的遗传易感性中发挥重要作用。重要的是,IPF 和 HP 共享一些 SP 遗传变异,提示关于表面活性剂生物发生的共同病理生理机制和途径,但也存在一些差异,突出了炎症驱动的纤维化(HP)和上皮驱动的纤维化(IPF)之间潜在的发病机制的多样性。或者,这里鉴定的显著 SNP 与其他基因的 SNP 一起,可以作为区分这两种毁灭性疾病的标记。